Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 659-668

  Ferry, David R ^a   Smith, Anna ^a   Malkhandi, Joy ^a   Fyfe, David W ^a   DeTakats, Philippa G ^a   Anderson, David ^a   Baker, Jim ^a   Kerr, David J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLAVONOID; PROTEIN TYROSINE KINASE; QUERCETIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; ENZYME INHIBITION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0029999052     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Swain, T. The Flavonoids. London: Chapman and Hall, 1975.
2. Anton, R. Flavonoids and Traditional Medicine. New York: Alan R. Liss, Inc., 1988.
3. Kuhnau, J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet, 24. 117-191, 1976.
4. Bokkenheuser, V. D., and Winter, J. Hydrolysis of flavonoids by human intestinal bacteria. In: V. Cody, E. Middleton, J. B. Harbourne, and A. Beretz (eds.), Plant Flavonoids in Biology and Medicine II, pp. 143-145. New York: Alan R. Liss, Inc., 1988.
5. Hertog, M. G. L., Hollman, P. C. H., Katan, M. B., and Kromhout, D. Intake of potentially anti carcinogenic flavonoids and there determinants in adults in the Netherlands. Nutr. Cancer. 20: 21-29, 1993.
6. + adenosine triphosphatase and its partial reactions by quercetin. Biochemistry. 15: 4951-4958, 1974.
7. Hoffmann, J., Doppler, W., Jakob. A., Maly, K., Posch, L., Uberall, F., and Grunicke, H. H. Enhancement of the antiproliferative effects of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int J. Cancer. 42: 382-388, 1988.
8. Srivastava, A. K. Inhibition of phosphorylase kinase and tyrosine protein kinase activities by quercetin. Biochem. Biophys. Res. Commun., 131: 1-5, 1985.
9. Ono, K., Nakane, H., Fukushima, M., Cherman, J-C., and BarreSinoussi, F. Differential inhibitory effects on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur. J. Biochem., 190: 469-476, 1990.
10. 2+)-ATPase of sarcoplasmic reticulum. J. Biol. Chem., 256: 887-892, 1981.
11. src. Nauyn-Schmeideberg Arch. Pharmakol., 317: 100-102, 1981.
12. 1 phase of the cell cycle. Cancer Res., 52: 6676-6681, 1992.
13. Yoshida, M., Sakai, T., Hosokawa, N., Marui, N., Matsumoto, K., Fujioka, A., Nishino, H., and Aoike, A. The effects of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett., 260: 10-13, 1990.
14. Wei, Y-q., Zhou. Y., Kariya, Y., Fukata, H., Teshigawara, K., and Uchida, A. Induction of apoptosis by quercetin: Involvement of heat shock proteins. Cancer Res., 54: 4952-4957, 1994.
15. Avalia, M., Velasco, J. A., Cansando, J., and Notario, V. Quercetin mediates down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res., 54: 2424-2428, 1994.
16. Matter, W. F., Brown, R. F., and Vlahos, C. J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogues. Biochem. Biophys. Res. Commun., 186: 624-631, 1992.
17. Yeh, Y. A., Herenyiova, M., Sledge, G. W., and Weber, G. Synergistic action of quercetin and carboxyamido-triazole in human breast carcinoma cell lines. Proc. Am. Assoc. Cancer Res., 36: 295, 1995.
18. Rizzo, M. T., and Weber, G. 1-phosphotidylinositol 4-kinase: an enzyme linked with proliferation and malignancy. Cancer Res., 54: 2611-2614, 1994.
19. Scambia, G., Ranelletti, F. O., Benedetti, P., Piantelli, M., Bonanno, G., De Vincenzo, R., Ferrandina, G., Rumi, C., Larocca, L. M., and Mancuso, S. Inhibitory effect of quercetin on OVA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br. J. Cancer, 62: 942-946, 1990.
20. Yanagihara, K., Ito, A., Toge, T., and Numoto, M. Antiproliferative effects of isoflavones on human cancer cell lines, established from the gastrointestinal tract. Cancer Res., 53: 5815-5821, 1993.
21. Hoffmann, J., Fiebig, H. H., Winterhalter, B. R., Berger, D. P., and Grunicke, H. Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer, 45: 530-539, 1990.
22. Scambia, G., Ranelletti, F. O., Benedetti, P. P., Piantelli, M., Bonanno, G., De, V. R., Ferrandina, G., Distefano, M., and Mancuso, S. Inhibitory effect of quercetin (q) on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum(II) (CDDP). Proc. Am. Soc. Clin. Oncol., 11: 760, 1992.
23. Teofili, L., Pierelli, L., Iovino, S., Leone, G., Scambia, G., De Vincenzo, R., Benedetti-Panici, P., Menichella, G., Marct, E., Piantelli, M., Ranaletti, F. O., and Larocca, L. M. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk. Res., 16: 479-503, 1992.
24. Gugler, R., Leschik, M., and Dengler, H. J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol., 9: 229-234, 1975.
25. Lui, B., Anderson, D., Ferry, D. R., deTakats, P. G., Seymour, L., and Kerr, D. J. Determination of quercetin in human plasma and blood using reverse phase HPLC. J. Chromatogr., B66: 149-155, 1995.
26. Calvert, A., Newell, D. R., Gumbrell, L. A., O'Reilley, S., Bumell, M., Boxall, F. E., Siddik, Z. H., Judson, I. R., Gore, M. E., and Wiltshaew, E. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J. Clin. Oncol., 11: 1748-1756, 1989.
27. Rustin, G. J., van, d. B. M., Berek, J. S. Advanced ovarian cancer. Tumour markers. Ann Oncol., 4 (Suppl. 4): S71-S77, 1993.
28. Bishop, J. M. The molecular genetics of cancer. Science (Washington DC), 235: 305-311, 1987.
29. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
30. Levitzki, A., and Gilon, C. Tyrphostins, a novel concept for antiproliferative drugs. In: J. A. Hickman and T. R. Tritton (eds.). Cancer Chemotherapy, pp. 107-127. Oxford: Blackwell Scientific Publications, 1993.
31. Marshall, L. F., Camp, P. E., and Bowers, S. A. Dimethylsulphoxide for the treatment of intracranial hypertension: a preliminary report. Neurosurgery, 14: 659-663, 1984.
32. Munther, S., and Bennett, W. M. Effects of dimethyl sulfoxide on renal function in man. J. Am. Med. Assoc., 244: 2081-2083, 1980.
33. Duarte, J., Ferez-Vizcaino, F., Zarzuelo, A., Jimenez, J., and Tamargo, J. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur. J. Pharmacol., 239: 1-7, 1993.
34. Beretz, A , Stoclet, J., and Anton, R. Inhibition of isolated rat aorta contractions by flavonoids. Possible correlation with cAMP-phosphodiesterase inhibition. Planta Med., 39: 236-241, 1980.
35. Brezis, M , and Epstein, F. H. Cellular mechanisms of acute ischaemic injury in the kidney. Annu. Rev. Med., 44: 22-37, 1993.
36. Cheisi, M., and Schwaller, R. Inhibition of constitutive NO-synthase activity by tanin and quercetin. Biochem Pharmacol., 49: 495-501, 1995.
37. Tumey, J H Acute renal failure, some progress? N. Engl. J Med., 331: 1372-1374, 1994.
38. Scambia, G., Ranelletti, F. O., Benedetti, P., Piantelli, M., Bonanno, G., De Vicenzo, R., Ferrandina, G., Pierelli, L., Capelli, A., and Mancuso, S. Quercetin inhibits the growth of a multidrug resistant oestrogenreceptor negative MCF-7 human breast-cancer cell line expressing type II oestrogen-binding sites. Cancer Chemother Pharmacol., 28: 255-258, 1991.
39. 6-methyldeoxyguanosine formation in peripheral blood cells of patients receiving CB10-277. Proc. Am. Assoc. Cancer Res., 35: 468, 1994.
40. Reed, E., Ozols, R. F., Tarone, R., Yuspa, S H., and Poirier, M. C. Platinum-DNA adducts in leucocyte DNA correlate with disease response in ovarian cancer patients receiving platinum based chemotherapy. Proc. Natl. Acad. Sci USA, 84: 5024-5028, 1987.